ArticleInternational journal of clinical pharmacy2026
Pathway to Access UTI Management (PATH-UTI): evaluating pharmacist prescribing and management practices for uncomplicated urinary tract infections in community pharmacy in New South Wales and the Australian Capital Territory, Australia.
Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionPharmacist prescribing has been introduced internationally to improve timely access to treatment in primary care. For uncomplicated urinary tract infections, pharmacist-led services report favourable outcomes, however, the evidence base remains limited by small sample sizes and heterogenous study designs. Large-scale evaluations are needed to better understand pharmacist management practices and prescribing outcomes.
aimTo explore pharmacist management practices for uncomplicated urinary tract infections in community pharmacy settings, including the effectiveness and safety of pharmacist prescribing and variation in clinical outcomes by antibiotic type.
methodData from the PATH-UTI cohort study were analysed across community pharmacies in New South Wales and the Australian Capital Territory. The trial included an initial two-month feasibility pilot followed by a 10-month main study period (July 2023-May 2024). Women aged 18-65 years presenting with symptoms consistent with an uncomplicated urinary tract infection were assessed and managed by trained pharmacists using a structured clinical management protocol aligned with national guidelines. Consultation data were routinely recorded during the pharmacy visit, and patient-reported outcomes were collected by follow-up survey 7 days later. The primary outcome was self-reported complete symptom resolution at 7-day follow-up. Secondary outcomes included antibiotic prescribing rates, patient reported adherence, referrals, and patient reported adverse events. Differences in symptom resolution by antibiotic type were assessed using a chi-square test of independence.
resultsA total of 18,143 consultations were recorded, with 14,680 follow-up surveys (81.0%) completed. Antibiotics were supplied in 92.6% of consultations, most commonly trimethoprim (95.5%). Complete symptom resolution at 7 days was reported by 79.4% of patients. A further 17.9% reported partial symptom improvement. There was no statistically significant difference in effectiveness across the three antibiotics (χ
conclusionPharmacist prescribing for uncomplicated urinary tract infections achieved symptom resolution rates comparable to previous pharmacy- and physician-led studies. Low rates of adverse events and complications, and strong adherence to the clinical management protocol were also observed. These results suggest that structured, protocol-based pharmacist prescribing for uncomplicated urinary tract infections can support safe and effective management in primary care, with the potential to improve access to treatment and help manage demand on general practice.
trial registrationRetrospectively registered: ACTRN 12623000882628.
Indexed as
Identifiers
42776432What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.